Intra-Cellular Therapies Inc. buy Piper Sandler
Start price
06.09.24
/
50%
€67.00
Target price
06.09.25
€82.70
Performance (%)
83.58%
End price
07.09.25
-
Summary
This prediction is currently being closed. With a performance of 83.58% the BUY prediction by Piper_Sandler is a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Piper_Sandler for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $92.00 price target on the stock, up previously from $68.00.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten